RECURSION PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.2 USD | +0.99% |
|
+7.89% | -16.84% |
| 04-18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
| 04-16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
Chart calendar Recursion Pharmaceuticals, Inc.
ec0a6d99cb73fcf6494ea702ce2375.vZy4uAAgV7Y5at6ooDXDzF2MWNM9n5Xy1qNZZb85dzM.zv3U8lV0Z-9RGLjNzGqHrTjnaL5b18aco5duMdd1G3zY7e2KRBUggAorsQ~1dcd84e9bddff548e7ac20f47d6e4795
Upcoming events on Recursion Pharmaceuticals, Inc.
Past events on Recursion Pharmaceuticals, Inc.
| 08/04/2024 15:15 | Needham Healthcare Conference |
| 18/03/2024 | KeyBanc Life Sciences & MedTech Forum |
| 11/03/2024 18:00 | Leerink Partners Global Biopharma Conference |
| 05/03/2024 19:00 | KeyBanc Emerging Technology Summit |
| 04/03/2024 21:25 | Morgan Stanley Technology, Media & Telecom Conference |
| 27/02/2024 22:00 | Q4 2023 Earnings Call |
| 27/02/2024 21:05 | Q4 2023 Earnings Release |
| 16/01/2024 14:30 | Needham Growth Conference |
| 08/01/2024 15:30 | JPMorgan Healthcare Conference |
| 14/11/2023 08:00 | Jefferies London Healthcare Conference |
| 09/11/2023 12:58 | Q3 2023 Earnings Release |
| 27/09/2023 14:30 | Goldman Sachs Global Sustainability Forum |
| 26/09/2023 16:05 | Cantor Global Healthcare Conference |
| 08/09/2023 14:00 | Citi Global Technology Conference |
| 07/09/2023 12:15 | Citi BioPharma Conference |
| 08/08/2023 16:30 | KeyBanc Technology Leadership Forum |
| 08/08/2023 12:58 | Q2 2023 Earnings Release |
| 28/06/2023 | Morgan Stanley Biotechnology AI Summit |
| 16/06/2023 19:00 | Annual General Meeting |
| 13/06/2023 21:20 | Goldman Sachs Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,96 | 10,2 12,4 -17.66% | 39,8 51,2 -22.25% | 44,6 52,1 -14.47% | 53,9 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -174 -175 0.11% | -234 -256 8.74% | -326 -307 -6% | -409 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -183 -174 -4.89% | -246 -227 -8.46% | -350 -342 -2.41% | -425 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -186 -163 -14.4% | -239 -216 -11.13% | -332 -329 -0.81% | -438 |
|
Net income Million USD | Released Forecast Spread | -87,0 | -186 -177 -5.45% | -239 -226 -6.11% | -328 -333 1.49% | -411 |
|
EPS USD | Released Forecast Spread | -5,99 | -1,49 -1,20 -24.25% | -1,36 -1,39 2.44% | -1,58 -1,66 5.01% | -1,70 |
| Announcement Date | 03/03/21 | 23/03/22 | 27/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,53 6,07 -58.25% | 5,33 84,0 -93.65% | 7,67 5,40 42.11% | 13,2 6,85 92.12% | 13,7 24,0 -43.02% | 12,1 13,2 -7.75% | 11,0 11,9 -7.54% | 10,5 12,9 -18.16% | 10,9 20,4 -46.49% | 13,1 | 13,6 | 14,2 | 14,4 | 13,5 |
|
EBITDA Million USD | Released Forecast Spread | -59,6 -75,0 20.55% | -66,1 -113 41.21% | -76,2 -63,7 -19.58% | -91,4 -85,5 -6.87% | -91,3 | -91,3 | -89,8 | -185 | -201 | |||||
|
EBIT Million USD | Released Forecast Spread | -65,0 -48,5 -33.94% | -56,0 -52,0 -7.66% | -66,2 -65,6 -0.92% | -62,6 -66,9 6.5% | -61,0 -49,8 -22.52% | -69,9 -63,0 -10.89% | -81,7 -73,1 -11.82% | -99,6 -81,9 -21.57% | -98,9 -87,9 -12.52% | -100 | -102 | -103 | -131 | -155 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -64,9 -43,0 -51.01% | -65,6 -57,0 -15.02% | -60,4 -61,0 0.91% | -57,5 -13,0 -342.25% | -65,3 -62,0 -5.37% | -76,7 -69,0 -11.2% | -93,0 -82,0 -13.44% | -94,6 -94,4 -0.24% | -106 | -106 | -108 | -117 | ||
|
Net income Million USD | Released Forecast Spread | -64,9 -50,0 -29.87% | -56,0 87,3 -164.12% | -65,6 -60,6 -8.27% | -60,4 -63,1 4.21% | -57,5 -45,9 -25.25% | -65,3 -60,2 -8.48% | -76,7 -70,6 -8.62% | -93,0 -77,5 -20.01% | -93,0 -96,7 3.87% | -98,9 | -99,4 | -99,7 | -126 | -155 |
|
EPS USD | Released Forecast Spread | -0,38 -0,30 -28.26% | -0,33 0,51 -164.71% | -0,38 -0,35 -10.1% | -0,35 -0,36 3.22% | -0,30 -0,25 -20% | -0,34 -0,34 -0.43% | -0,38 -0,37 -3.55% | -0,43 -0,38 -12.99% | -0,42 -0,45 6.69% | -0,42 | -0,41 | -0,41 | -0,48 | -0,68 |
| Announcement Date | 23/03/22 | 10/05/22 | 09/08/22 | 08/11/22 | 27/02/23 | 08/05/23 | 08/08/23 | 09/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Recursion Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RXRX Stock
- Calendar Recursion Pharmaceuticals, Inc.
